Thar Pharmaceuticals' Series A - III Round

Thar Pharmaceuticals raised a round of funding on November 18, 2011.

Thar Pharmaceuticals is a clinical stage biopharmaceutical company that focuses on developing and commercializing a pipeline of oral therapies for serious and life-threatening conditions. The company'…

Articles about Thar Pharmaceuticals' Series A - III Round: